Journal article
Immune modulation in autologous bone marrow transplantation: cyclosporine and gamma-interferon trial
Abstract
From March 1994 to November 1994, 16 patients with high risk hematological malignancies were entered in a phase I clinical trial, designed to confirm the toxicity of cyclosporine and gamma interferon given to induce autologous graft-versus-host disease (GVHD) after autologous bone marrow transplantation (ABMT). This trial was based on the results in a rodent model, in which cyclosporine given after ABMT induces an autoimmune syndrome …
Authors
Vogelsang G; Bitton R; Piantadosi S; Altomonte V; Horn T; Jones R; Miller C; Marcellus D; Abrams R; Hess A
Journal
Bone Marrow Transplantation, Vol. 24, No. 6, pp. 637–640
Publisher
Springer Nature
Publication Date
September 1, 1999
DOI
10.1038/sj.bmt.1701942
ISSN
0268-3369